January 30, 2015 12:40 AM ET


Company Overview of Advanced Accelerator Applications S.A.

Company Overview

Advanced Accelerator Applications S.A., a radiopharmaceutical company, develops, produces, and commercializes molecular nuclear medicine (MNM) diagnostic and therapeutic products in France, Italy, Spain, Israel, Canada, the United States, and internationally. It provides positron emission tomography (PET) products, including Gluscan, a branded 18-fluorodeoxyglucose PET imaging agent that assists in the diagnosis of serious medical conditions primarily in oncology through assessing glucose metabolism; IASOflu, which images bone metastases; IASOdopa to diagnose Parkinson’s disease and tumors in various indications; and IASOcholine for diagnosing prostate cancer. The company also offers single-...

20 Rue Diesel

Saint Genis Pouilly,  01630


Founded in 2002

324 Employees


33 4 50 99 30 70


33 4 50 99 30 71

Key Executives for Advanced Accelerator Applications S.A.

Age: 48
Group Chief Financial Officer
Age: 51
Chief Operating Officer
Age: 56
Head of Clinical Development
Age: 59
Chief Medical Officer
Compensation as of Fiscal Year 2014.

Advanced Accelerator Applications S.A. Key Developments

Advanced Accelerator Applications S.A. Announces Earnings Results for the First Nine Months of 2014

Advanced Accelerator Applications S.A. announced earnings results for the first nine months of 2014. For the nine months, sales of EUR 50,156,000 compared to EUR 38,919,000 a year ago. Operating income was EUR 2,199,000 compared to EUR 1,373,000 a year ago. Net income from continuing operations was EUR 1,135,000 compared to loss of EUR 2,038,000 a year ago. Adjusted EBITDA was EUR 9,668,000 compared to EUR 7,643.000 a year ago. Net operating cash-flow was EUR 9 million, an increase of 33% compared to the 6.7 million a year ago.

Advanced Accelerator Applications SA Announces Earnings Results for the Full Year Ended December 31, 2013

Advanced Accelerator Applications SA announced earnings results for the full year ended December 31, 2013. For the period, the company reported net loss for the year from continuing operations of EUR 9,861,000 compared with EUR 16,912,000 for the same period a year ago. EBITDA was EUR 10,638,000 compared with EUR 6,577,000 for the same period a year ago. Sales for the year increased by 31.77% to EUR 53.8 million compared with EUR 40.8 million for the same period a year ago.

Advanced Accelerator Applications SA Appoints Kapil Dhingra as Independent Non-Executive Director

Advanced Accelerator Applications S.A. announced that Dr. Kapil Dhingra has joined the company Board of Directors as an Independent Non-Executive Director. Dr. Dhingra has over 25 year's experience in oncology clinical research and drug development, including nine years at Roche Pharmaceuticals, where he played a key role in the expansion of Roche Oncology. From 1999 to 2008 he served in positions of increasing responsibility at Roche, including Vice President, Head, Oncology Disease Biology Leadership Team, and Head, Oncology Clinical Development. Prior to his time at Roche, Dr. Dhingra worked in the oncology clinical development group at Eli Lilly and Company. He has also previously served as a Clinical Instructor, Assistant Professor of Medicine at the University of Texas M.D. Anderson Cancer Center. Dr. Dhingra holds an M.B.,B.S. (equivalent to a U.S. M.D.) degree from the All India Institute of Medical Sciences. He is Board-certified in Internal Medicine and Medical Oncology.

Similar Private Companies By Industry

Company Name Region
Oncophyt Europe
Laboratoire GlaxoSmithKline S.A.S. Europe
Meiogenix SAS Europe
Gemacbio S.A Europe
LFB Biomanufacturing S.A.S. Europe

Recent Private Companies Transactions

January 8, 2015
AAA Canada
March 4, 2014
Imaging Equipment Ltd
Private Placement
February 17, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Advanced Accelerator Applications S.A., please visit www.adacap.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.